Login / Signup

Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an ESR1 Mutation.

Einav Nili Gal-YamKeren Levanon
Published in: JCO precision oncology (2023)
Keyphrases
  • estrogen receptor
  • metastatic breast cancer
  • case report
  • combination therapy
  • disease activity
  • open label
  • ulcerative colitis
  • rheumatoid arthritis
  • clinical trial
  • systemic lupus erythematosus